Differentiation of Central Lung Cancer from Atelectasis: Comparison of Diffusion-Weighted MRI with PET/CT

Abstract

ObjectiveProspectively assess the performance of diffusion-weighted magnetic resonance imaging (DW-MRI) for differentiation of central lung cancer from atelectasis.Materials and Methods38 consecutive lung cancer patients (26 males, 12 females; age range: 28–71 years; mean age: 49 years) who were referred for thoracic MR imaging examinations were enrolled. MR examinations were performed using a 1.5-T clinical scanner and scanning sequences of T1WI, T2WI, and DWI. Cancers and atelectasis were measured by mapping of the apparent diffusion coefficients (ADCs) obtained with a b-value of 500 s/mm2.ResultsPET/CT and DW-MR allowed differentiation of tumor and atelectasis in all 38 cases, but T2WI did not allow differentiation in 9 cases. Comparison of conventional T2WI and DW-MRI indicated a higher contrast noise ratio of the central lung carcinoma than the atelectasis by DW-MRI. ADC maps indicated significantly lower mean ADC in the central lung carcinoma than in the atelectasis (1.83±0.58 vs. 2.90±0.26 mm2/s, p<0.0001). ADC values of small cell lung carcinoma were significantly greater than those from squamous cell carcinoma and adenocarcinoma (p<0.0001 for both).ConclusionsDW-MR imaging provides valuable information not obtained by conventional MR and may be useful for differentiation of central lung carcinoma from atelectasis. Future developments may allow DW-MR imaging to be used as an alternative to PET-CT in imaging of patients with lung cancer.

Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC

“…Hence, respiratory gated T2weighted sequence can adequately assess the ultrastructure of the lungs in the early and late phase after chemoradiation to diagnose or exclude RILT. Differentiating between treatment effects like RILT or tumoratelectasis-complex and residual or recurrent tumor, is challenging [31]. Like aforementioned, in some cases of the presented group, by using DWI, as compared to CT, we were able to delineate recurrences earlier and to more reliably rule out recurrence within lung parenchyma altered by RILT (Fig.…”

Is it better to include necrosis in apparent diffusion coefficient (ADC) measurements? The necrosis/wall ADC ratio to differentiate malignant and benign necrotic lung lesions: Preliminary results

“…Echo‐planar imaging (EPI), the use of high gradient amplitudes, and multichannel coils reduced the distortion, improved the signal‐to‐noise ratio, and strengthened our study . The features of the adequate contrast resolution, the absence of ionizing radiation, and no requirement for contrast material was beneficial …”

Diffusionsbildgebung: Technik und klinische Anwendung

“…7). Ein Vorteil der DWI im Vergleich zur T2w Sequenz besteht darin, dass die DWI ähnlich wie die PET-CT zwischen Tumorgewebe und poststenotischer Atelektase unterscheiden kann [7].…”